期刊文献+

肝素涂层医用聚氯乙烯的细胞毒性研究 被引量:5

Cytotoxicity Study of Heparin Coated Polyvinyl Chloride Material
下载PDF
导出
摘要 本研究通过肝素—氯烃基二甲基代苯甲胺复合物(A组)、肝素—苯扎溴胺复合物(B组)和肝素—聚乙烯亚胺复合物对医用聚氯乙烯体外循环管道进行了肝素涂层,同时采用材料直接接触细胞培养法和四唑盐(MTT)比色试验评价各种涂层材料的细胞毒性。结果显示A、B组材料直接接触L-929细胞后24h即引起细胞大量死亡,而C组材料直接接触后具有良好的细胞相容性。MTT比色试验也表明A、B两种涂层材料具有较低的OD值。A、B两种涂层材料具有较强的细胞毒性,而C方法处理的聚氯乙烯材料不引起细胞死亡,具有进一步临床应用前景。 In this study, heparin ionically coated polyvinyl chloride (PVC) material was prepared by heparinbenzalkonium chloride complex (Group A), heparin-benzalkonium bromide complex (Group B) and heparinpolyethyleneimine compound (Group C). Cytotoxicity evaluation was conducted by direct cell contact evaluation and MTT colorimetry method. The results showed Group A and Group B caused L-929 cells to die out while Group C showed good compatibility with cells. The OD levels of Group A and B were lower than that of the Group C in MTT test. Method A and method B of heparin coating had remarkable cytotoxicity, while method C had little cytotoxicity and could be further studied for clinical use.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2005年第4期739-741,共3页 Journal of Biomedical Engineering
  • 相关文献

参考文献8

  • 1Belboul A, Akbar O, Lofgren C, et al. Improved blood cellular biocompatibility with heparin coated circuits during cardiopul-monary bypass. J Cardiovasc Surg, 2000; 41∶357.
  • 2杨剑,易定华,钟丽辉,范圣强,曹瑞军,金锋,邵继凤.肝素涂层体外循环管道抗凝血性能的研究[J].生物医学工程与临床,2003,7(2):100-103. 被引量:6
  • 3ISO 10993-12: 2002; Biological evaluation of medical devices - Part 12: Sample preparation and reference materials.
  • 4ISO 10993-16:1997; Biological evaluation of medical devices-Part 16: Toxicokinetic study design for degradation products and leachables.
  • 5徐钢梅,张彩霞,宁丽,孙皎,孟爱英.MTT法评价镓合金的细胞毒性[J].中华口腔医学杂志,2001,36(3):189-192. 被引量:29
  • 6ISO 10993-5: 1999; Biological evaluation of medical devices-Part 5: Tests for cytotoxicity: in vitro methods.
  • 7Yourtee, Tong PY, Rose LA, et al. Effect of spiroorthocarbonate volume modifier comonomers on the in vitro toxicology of trial non-shrinking dental epoxy copolymers. Res Commun Mol Pathol Pharmacol, 1994; 86(3)∶347.
  • 8Hsu, Li-Chien, Hu, et al. Universal biocompatible coating platform for medical devices. US Patent: 6,309,660. 2001-10-30.

二级参考文献4

共引文献32

同被引文献39

  • 1张安兄,吕德龙,钟伟,程为庄,杜强国.生物材料的血液相容性[J].上海生物医学工程,2004,25(3):53-58. 被引量:27
  • 2林晓艳,范红松,李旭东,唐敏,张伶利,谭言飞,徐金瑞,张兴栋.纳米羟基磷灰石/胶原复合材料的制备及生物学评价[J].中国生物医学工程学报,2006,25(1):63-68. 被引量:9
  • 3[1]Sperling C,Houska M,Brynda E,et al.In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique[J].J Biomed Mater Res A,2006,76(4):681-689.
  • 4[2]Wendel HP,Ziemer G.Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation[J].Eur J Cardiothorac Surg,1999,16(3):342-350.
  • 5[4]Hsu LC.Biocompatibility in eardiopulmonary bypass[J].J Cardicthoracic Vasc Anesth,1997,11(3):376-382.
  • 6[7]Huang LY,Yang MC.Hemocompatibility of layer-by-layer hyaluronic acid/heparin nanostructure coating on stainless steel for cardiovascular stents and its use for drug delivery[J].J Nanosci Nanotechnol,2006,6(9-10):3163-3170.
  • 7[8]Thorslund S,Sanchez J,Larsson R,et al.Functionality and stability of heparin immobilized onto poly(dimethylsiloxane)[J].Colloids Surf B Biointerfaces,2005,45(2):76-81.
  • 8[9]Lappegard KT,Riesenfeld J,Brekke OL,et al.Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production[J].Ann Thorac Surg,2005,79(3):917-923.
  • 9Usui A, Oshima H, Akita T, et al. Polydioxane (PDS) cord has insufficient reliability to securely close the sternum [J]. J Thorac Cardiovasc Surg, 2006, 131(5): 1174-5.
  • 10Luciani N, Anselmi A, Possati G. Adjusting the indication to polydioxane suture for elective sternal closure [J]. J Thorae Cardiovasc Surg, 2006, 132(5): 1243.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部